Euglena
VC Fund
Tokyo, Japan
Euglena is a VC fund in Tokyo focused on Health Care and Biotechnology. euglena Co., Ltd. engages in the research, development, production, and sale of microalgae with a focus on euglena. The company also manufactures and sells foods and cosmetics using euglena. It offers green juices, cookie bars, beverages, dietary supplements, and raw materials, as well as contract manufacturing/processing services; and skincare products.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Euglena invests in
Stages Euglena invests in
Countries Euglena invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 3 (38%)
- Biotechnology 3 (38%)
- Snack Food 2 (25%)
- Food and Beverage 2 (25%)
- SNS 1 (13%)
Stage
- Seed 3 (38%)
- Series A 3 (38%)
- Funding Round 1 (13%)
- Venture - Series Unknown 1 (13%)
Country
- Japan 7 (88%)
- United States 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Mitsuru Izumo
Representative Director and President
|
Representative Director and President | Total investments: 1 | Find email | |
Akihiko Nagata
Executive Vice President COO
|
Executive Vice President COO | Total investments: 9 | Find email | |
Daisuke Susa
Executive Officer
|
Executive Officer | Total investments: 0 | Find email | |
Junnosuke Awa
Executive Officer
|
Executive Officer | Total investments: 0 | Find email | |
Kengo Suzuki
Co-Founder & Executive Officer Research and Development
|
Co-Founder & Executive Officer Research and Development | Total investments: 4 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Misaky Tokyo
|
MisakyTokyo provides food and beverage services. | $3.7M / Seed / Nov 21, 2023 | |
KAICO
|
KAICO is a pharmaceuticals, diagnostic drugs production company. | $2.3M / Series A / Dec 15, 2021 | |
Minimal - Bean to Bar Chocolate
|
Minimal - Bean to Bar Chocolate sells cacao beans and handmade chocolate. Their product line includes chocolate rare cheesecake, cacao tours, chocolate bars, sweets, chocolate sandwich cookies, and sweets. Their products serve consumers. | Venture - Series Unknown / Jul 13, 2020 | |
NeuroSpace
|
NeuroSpace is a science venture that leads human's 24 hours to a new level with Neuroscience Technology, which elucidates the mystery of sleep . | $35.4M / Series A / Apr 08, 2019 | |
Medcare
|
Medcare is a medical service corporation. | $86.5M / Series A / Apr 27, 2018 | |
Pocket Marche
|
Pocket Marche is a smartphone app that allows you to buy food while talking with farmers and fishermen across the country. | $25.5M / Seed / Sep 29, 2017 | |
Amelieff
|
Amelieff provides bioinformatic skills and knowledge to help bio-researchers. The company's bioinformaticians analyzes data by using open-source software and in-house developed tools. The company delivers data analysis servers made of widely used bioinformatics software. Servers may be customized on request, such as organisms’ genome. Thecompany also offers bioinformatics skill training. Training can be at a desired site and schedule, and the contents may be customized to customers demands.Amelieff was founded in July 2009 and is headquartered in Tokyo, Japan. | $7.1M / Feb 15, 2016 | |
Meltin MMI
|
Meltin MMI is a cyborg-technology company that focuses on biosensors and robotic arms. Meltin has successfully enabled fine finger movements, such as for amputees and participated in Cybathlon 2016 and won the Microsoft Innovation Award. | $8.5M / Seed / Feb 15, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Euglena invest in?
Euglena invests primarily in Health Care, Biotechnology and Snack Food startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Euglena?
Public channels for Euglena include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Euglena?
The team at Euglena includes Mitsuru Izumo (Representative Director and President), Akihiko Nagata (Executive Vice President COO) and Daisuke Susa (Executive Officer), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
